Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison Study of Helicobacter Pylori Eradication Rates Between Daily Four Times and Daily Two Times Usage of Proton Pump Inhibitor and Amoxicillin for the First Line and the Second Line Eradication Therapy

NCT03802318 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT03802318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03802318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison Study of Helicobacter Pylori Eradication Rates Between Daily Four Times and Daily Two Times Usage of Proton Pump Inhibitor and Amoxicillin for the First Line and the Second Line Eradication Therapy
Lead sponsor
Chang Gung Memorial Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 2, 2019
Completion date
December 31, 2020
Enrollment
530 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter gastritis, helicobacter pylori infection, helicobacter-associated pyloric ulcer